Kymera Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of KYMR for the last quarter is 3.74 M USD, and it's 85.42% lower compared to the previous quarter. The net income of Q3 24 is -62.49 M USD.